Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Markets

North American Uranium Market Stalls Amid Tariff Uncertainty and Utility Hesitation

by Team Lumida
March 31, 2025
in Markets
Reading Time: 4 mins read
A A
0
a piece of rock sitting on top of a table

Photo by PAVAN JAMDAR on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • U.S. nuclear power companies are significantly reducing uranium purchases due to impending tariffs, with utility purchases dropping by half as they await clarity on President Trump’s 10% levy on Canadian energy exports.
  • The U.S. relies on Canada for over 25% of its uranium supply, making the sector particularly vulnerable to tariff-related disruptions.
  • Despite the current market turmoil, utilities are well-supplied for 2025 and most of 2026 due to long-term contracts, but uncertainty is causing hesitation in signing new agreements.
  • The uranium market has seen a notable decline, with a key ETF for uranium miners down 14% this year, and futures prices falling approximately 40% from their 2024 peak.

What Happened?

The North American uranium market is experiencing a significant slowdown as U.S. nuclear power companies react to President Trump’s tariff threats. With the imposition of a 10% tariff on Canadian energy exports approaching, utility purchases of uranium have halved, according to data from pricing firm TradeTech.

Utilities, which typically rely on long-term contracts for uranium supply, are currently hesitant to make new purchases, opting instead to wait and see how the tariff situation unfolds. This uncertainty is particularly concerning for the U.S. nuclear sector, which sources more than a quarter of its uranium from Canada.

Despite the current market conditions, Cameco Corp., North America’s largest uranium producer, has indicated that there is no immediate risk of fuel shortages for U.S. reactors, as utilities are adequately supplied for the near term. However, the ongoing uncertainty is complicating decision-making for utility executives, who are trying to balance expansion plans with fluctuating electricity demand.


Why It Matters?

The uranium market’s paralysis highlights the broader implications of trade policies on critical energy sectors. With the U.S. being the largest uranium buyer globally, any disruptions in supply chains can have significant repercussions for energy production and pricing.

The hesitance of utilities to sign new contracts could lead to future supply challenges, especially as some utilities are expected to need additional uranium as soon as 2027 or 2028. The current situation underscores the importance of stable trade relations and clear policies for the energy sector’s long-term planning and investment.


What’s Next?

As the tariff announcement approaches, market participants will be closely monitoring developments and any potential changes in U.S.-Canada trade relations. The outcome of these tariffs could reshape the uranium supply landscape and influence future pricing and availability.

Utilities may need to adapt their strategies to secure uranium access while managing costs, especially if tariffs are implemented. The ongoing uncertainty may also prompt further discussions among industry stakeholders about the need for more stable and predictable trade policies to support the nuclear energy sector.

Source
Previous Post

Bitcoin Approaches $81K as XRP and ADA Slide Amid Tariff War Concerns

Next Post

Chevron Sells 70% Stake in East Texas Gas Assets for $525 Million to Optimize Portfolio

Recommended For You

Google Bets on California Consolidation to Win the AI Race — Appointing Kavukcuoglu as Hassabis Steps Back, as Researchers Flee to Rivals and Jeff Dean Launches Startup

by Team Lumida
18 hours ago
Alphabet $GOOGL Q2 2024 Results

Google is concentrating its AI leadership in Mountain View, appointing Koray Kavukcuoglu — mentored by Yann LeCun, now the only remaining Gemini co-lead — to run its sprawling...

Read more

Aschenbrenner Returns to Investing With $400 Million Private Bet Days After SA Nearly Collapsed — Got Married Mid-Crisis to Anthropic CEO’s Chief of Staff

by Team Lumida
18 hours ago
Leopold Aschenbrenner’s Situational Awareness Fund Down 67% in July — Citadel Steps In to Buy the AI Stock Portfolio

Leopold Aschenbrenner made a $400 million investment in an undisclosed private company on Tuesday — just days after Situational Awareness nearly buckled under margin calls that collapsed its...

Read more

SoftBank Piles On: $10 Billion Margin Loan Backed by OpenAI Stake Brings Total OpenAI Exposure to ~$65 Billion by October

by Team Lumida
18 hours ago
SoftBank’s Narrow Gain: How AI Investments Shape the Future

SoftBank secured a $10 billion two-year margin loan from Goldman Sachs, JPMorgan, Mizuho, Apollo, and SMBC backed by its OpenAI preferred share stake — adding to the $40...

Read more

The A-List Behind Situational Awareness — D1’s Sundheim, Greenoaks’ Mehta, and Tiger Global’s Dewan Backed a 20-Something With No Track Record on the AI Trade

by Team Lumida
2 days ago
Leopold Aschenbrenner’s Situational Awareness Fund Down 67% in July — Citadel Steps In to Buy the AI Stock Portfolio

WSJ reveals the elite investor roster behind Situational Awareness — the AI hedge fund that lost ~67% in July — which was backed by D1 Capital's Dan Sundheim,...

Read more

SpaceX Spent $15.8 Billion on AI in One Quarter — Doubled Its Prior Spend and Is Just Getting Started

by Team Lumida
2 days ago
SpaceX’s IPO Is So Big It’s Forcing Wall Street to Rewrite Its Own Rules

SpaceX reported $18.4 billion in total Q2 capital expenditures, with $15.8 billion tied specifically to its AI build-out — double the prior quarter — as Elon Musk's rocket...

Read more

Citadel Buys Situational Awareness Public Equities at 10% Discount, Triggering Relief Rally as Fund Assets Collapse From $45B to $10B

by Team Lumida
2 days ago
Ken Griffin Warns Trump-Era Political вмешening Is Distorting Corporate Decision-Making

Ken Griffin's Citadel purchased Situational Awareness's public equity portfolio at a 10% discount, triggering a relief rally across SA's former holdings as the fund's assets collapsed from $45...

Read more

Caterpillar Surges 11% as Data Center Power Demand Drives Record $72 Billion Backlog — AI Infrastructure Is Now CAT’s Biggest Business

by Team Lumida
3 days ago
a bulldozer in a dirt field

Caterpillar crushed Q2 estimates — $8.17 EPS vs. $6.17 expected, $20.5B revenue vs. $19B expected — as its power and energy unit, which makes generators and turbines for...

Read more

Apple’s Worst Day Since Tariffs, Microsoft’s Best Day Ever — Big Tech Earnings Split the Market as New Fed Chair Leaves Investors “Doved and Confused”

by Team Lumida
4 days ago
close-up photo of monitor displaying graph

A week of blockbuster tech earnings sent stocks sharply in opposite directions: Microsoft notched the largest single-session market cap gain in US history while Apple suffered its worst...

Read more

AstraZeneca Explores Mega-Merger With Bristol-Myers Squibb — Would Be Largest Pharma Deal in History at $107 Billion Combined RevenueAstraZenecaAstraZeneca Explores Mega-Merger With Bristol-Myers Squibb — Would Be Largest Pharma Deal in History at $107 Billion Combined Revenue

by Team Lumida
4 days ago
vitamin b 12 100 mg

AstraZeneca has held early-stage talks with Bristol-Myers Squibb about a potential combination that would create the world's largest drugmaker — a deal analysts say would be hard to...

Read more

Morgan Stanley Upgrades Korea to Overweight, Sees 36% Upside — “Leverage Washout” Creates Entry Point Into AI and Industrial Super-Cycle

by Team Lumida
4 days ago
Morgan Stanley Q2 2024 Earnings Summary

Morgan Stanley upgraded the Kospi to overweight with a 9,000 target — 36% above current levels — arguing that the index's 30%+ selloff from its June peak reflects...

Read more
Next Post
a chevron gas station at night time

Chevron Sells 70% Stake in East Texas Gas Assets for $525 Million to Optimize Portfolio

OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

SoftBank to Lead $40 Billion Funding Round for OpenAI, Valuing Company at $300 Billion

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

a black and white logo

Palantir Raises Full-Year Outlook Amid Surging AI Demand, Despite Stock Dip

May 6, 2025
Tax-Loss Harvesting Surge: JPMorgan’s $15 Billion Windfall

JPMorgan Files for Second Tokenized Money Market Fund as Wall Street Races Into On-Chain Finance

May 13, 2026
House GOP Faces Internal Divisions Over Trump’s $3.3 Trillion Tax-and-Spending Bill

House GOP Faces Internal Divisions Over Trump’s $3.3 Trillion Tax-and-Spending Bill

July 3, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018